Kashani-Sabet M - Search Results

1

Kijima H, Ishida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Kijima H, et al. Pharmacol Ther. 1995;68(2):247-67. doi: 10.1016/0163-7258(95)02008-x. Pharmacol Ther. 1995. PMID: 8719970 Review.

2

Reversal of the malignant phenotype by an anti-ras ribozyme.

Kashani-Sabet M, Funato T, Tone T, Jiao L, Wang W, Yoshida E, Kashfinn BI, Shitara T, Wu AM, Moreno JG, et al. Kashani-Sabet M, et al. Antisense Res Dev. 1992 Spring;2(1):3-15. doi: 10.1089/ard.1992.2.3. Antisense Res Dev. 1992. PMID: 1422085

3

The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas.

Funato T, Yoshida E, Jiao L, Tone T, Kashani-Sabet M, Scanlon KJ. Funato T, et al. Adv Enzyme Regul. 1992;32:195-209. doi: 10.1016/0065-2571(92)90017-t. Adv Enzyme Regul. 1992. PMID: 1496917

4

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.

Scanlon KJ, Jiao L, Funato T, Wang W, Tone T, Rossi JJ, Kashani-Sabet M. Scanlon KJ, et al. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10591-5. doi: 10.1073/pnas.88.23.10591. Proc Natl Acad Sci U S A. 1991. PMID: 1660142 Free PMC article.

5

Cisplatin resistance in human cancers.

Scanlon KJ, Kashani-Sabet M, Tone T, Funato T. Scanlon KJ, et al. Pharmacol Ther. 1991 Dec;52(3):385-406. doi: 10.1016/0163-7258(91)90033-i. Pharmacol Ther. 1991. PMID: 1820582 Review.

6

Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.

Kashani-Sabet M, Wang W, Scanlon KJ. Kashani-Sabet M, et al. J Biol Chem. 1990 Jul 5;265(19):11285-8. J Biol Chem. 1990. PMID: 2113532 Free article.

7

Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil.

Kashani-Sabet M, Lu Y, Leong L, Haedicke K, Scanlon KJ. Kashani-Sabet M, et al. Eur J Cancer. 1990 Mar;26(3):383-90. doi: 10.1016/0277-5379(90)90238-o. Eur J Cancer. 1990. PMID: 2141497

8

Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.

Scanlon KJ, Kashani-Sabet M, Sowers LC. Scanlon KJ, et al. Cancer Commun. 1989;1(4):269-75. Cancer Commun. 1989. PMID: 2534792

9

Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

Scanlon KJ, Kashani-Sabet M, Miyachi H, Sowers LC, Rossi J. Scanlon KJ, et al. Anticancer Res. 1989 Sep-Oct;9(5):1301-12. Anticancer Res. 1989. PMID: 2686531 Review.

10

Differential gene expression in human cancer cells resistant to cisplatin.

Scanlon KJ, Kashani-Sabet M, Miyachi H. Scanlon KJ, et al. Cancer Invest. 1989;7(6):581-7. doi: 10.3109/07357908909017533. Cancer Invest. 1989. PMID: 2698255 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters